MedNation AG
SWB:EIF
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.2
2.38
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
MedNation AG
Cost of Revenue
MedNation AG
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
MedNation AG
SWB:EIF
|
Cost of Revenue
-€7.9m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
Rhoen Klinikum AG
XETRA:RHK
|
Cost of Revenue
-€530.9m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
0%
|
|
|
M1 Kliniken AG
XETRA:M12
|
Cost of Revenue
-€275.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
|
Mediclin AG
XETRA:MED
|
Cost of Revenue
-€129.6m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-2%
|
|
|
MATERNUS-Kliniken-AG
XETRA:MAK
|
Cost of Revenue
-€21.7m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-1%
|
|
|
Eifelhoehen-Klinik AG
F:EIF
|
Cost of Revenue
-€7.9m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
MedNation AG
Glance View
MedNation AG operates facilities for the provision of inpatient and outpatient rehabilitation, elderly care and outpatient medical care. The company is headquartered in Bonn, Nordrhein-Westfalen and currently employs 470 full-time employees. The company went IPO on 2012-04-03. The company operates the Eifelhoehen-Klinik Marmagen GmbH in Nettersheim-Marmagen, a specialist clinic for outpatient and inpatient internal medicine, orthopedics/traumatology, neurology; the Kaiser-Karl-Klinik GmbH in Bonn, a specialist clinic for outpatient and inpatient orthopedics, geriatrics and internal medicine, as well as the Herzpark Moenchengladbach GmbH in Moenchengladbach, a specialist clinic for outpatient and inpatient cardiac rehabilitation. In addition to that it owns a majority stake in Aatalklinik Wuennenberg GmbH and a minority stake in geriatric center Zuelpich GmbH.
See Also
What is MedNation AG's Cost of Revenue?
Cost of Revenue
-7.9m
EUR
Based on the financial report for Jun 30, 2024, MedNation AG's Cost of Revenue amounts to -7.9m EUR.
What is MedNation AG's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-32%
Over the last year, the Cost of Revenue growth was 4%. The average annual Cost of Revenue growth rates for MedNation AG have been -2% over the past three years , -32% over the past five years .
You don't have any saved screeners yet
